• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

Development of new immune cell therapies with human leukemia model mouse.

Research Project

Project/Area Number 12557078
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Hematology
Research InstitutionDokkyo University School of Medicine

Principal Investigator

MITANI Kinuko  Dokkyo University School of Medicine, Department of Hematology, professor, 医学部, 教授 (50251244)

Co-Investigator(Kenkyū-buntansha) MAKI Kazuhiro  Dokkyo University School of Medicine, Department of Hematology, assistant professor, 医学部, 助手 (50337391)
WAGA Kazuko  Dokkyo University School of Medicine, Department of Hematology, lecturer, 医学部, 講師 (00285917)
NAKAMURA Yuichi  Dokkyo University School of Medicine, Department of Hematology, lecturer, 医学部, 講師 (20227896)
Project Period (FY) 2000 – 2003
KeywordsAML1 / EVI-1 / TGBβ / CtBP / AML1 / conditional knock-out mice / MEN / ノックアウト
Research Abstract

1.AML1/EVI-1 is a chimeric transcription factor that plays a causative role in blastic transformation of chronic myelogenous leukemia (CML) and myelodysplastic syndrome (MDS). AML1/EVI-1 repressed transcription through PAI-1promoter that was activated by TGFI3 signals. AML1/EVI-1specifically bound to an intracellular signal transducer of TGFβ, Smad3, and inhibited its functions. Because AMLI/EVI-1 bound to a corepressor CtBP, recruitment of histone deacetylase could be an underlying mechanism. AML1/EVI-1 also interfered with AMIL 1-mediated transcription through association with CtBP. Moreover, AML1/EVI-l blocked differentiation of 32D cells induced by G-CSF, depending on the CtBP-binding region in EVI-l portion. These data indicate that AMLI/EVI-1progresses CML or MIDS to acute leukemia partly through abolishing TGFβ signals and blocking AML1 functions.
2.We assessed the requirement of AML 1 in adult hematopoiesis using an inducible gene-targeting method. In the absence of AML 1, hematopoietic progenitors were fully maintained with normal myeloid development. However, AML 1-deficient bone marrow showed inhibition of megakaryocytic maturation, increased hematopoietic progenitor cells and defective T-and B-lymphocyte development. These data indicate that AML1 is required for maturation of megakaryocytes and differentiation of T and B cells, but not for maintenance of hematopoietic stem cells in adult hematopoiesis.
3.We generated knock-out mice of MEN. They were embryonic lethal, and die before E6.5 and after implantation. MEN was found to play a non-redundant role as an elongation factor in postimplantation development of mice.

  • Research Products

    (42 results)

All Other

All Publications (42 results)

  • [Publications] Kurokawa, M.: "The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death."EMBO J. 19. 2958-2968 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Imai, Y.: "Mutations of the AML1 gene in patients with myelodysplastic syndrome and their functional implications in leukemogenesis."Blood. 96. 3154-3160 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamagata, T.: "Acetylation of GATA-3 affects T-cell survival and homing to secondary lymphoid organ."EMBO J. 19. 4676-4687 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Mitani, K.: "Nonredundant roles of the elongation factor MEN in postimplantation development"Biochem Biophys Res Comm. 279. 563-567 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Imai, Y.: "Mutations of the Smad4 gene in acute myelogenous leukemia and their functional implications in leukemogenesis."Oncogene. 20. 88-96 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Izutsu, K.: "The corepressor CtBP interacts with Evi-1 to repress transforming growtβ signaling."Blood. 97. 2815-2822 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tadokoro, J.: "Low frequency of BCL10 gene mutations in B-cell Non-Hodgkin's lymphoma."Int J Hematol. 73. 222-225 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hirai, H.: "Oncogenic mechanisms of Evi-1 protein."Cancer Chem Pharm. 48. S35-S40 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakamura, Y.: "Expression od the TEL/EVI1 fusion transcript in a patient with chronic myelogenous leukemia with t(3;12)(q26;p13)."Am J Hematol. 69. 80-82 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Omine, K.: "Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells."Oncogene. 20. 8249-8257 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Izutsu, K.: "The t(3;21) fusion product, AML1/Evi-1, blocks AML1-induced transactivation by recruiting CtBP."Oncogene. 21. 2395-2703 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tsurumi, S.: "N-ras and p53 gene mutations in Japanese patients with myeloproliferative disorders."Am J Hematol. 71. 131-133 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Arai, H.: "Functional regulation of TEL by p38-induced phosphorylation."Biochem Biophys Res Comm. 299. 116-125 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Imai, Y.: "Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome."Leuk & Lymph. 43. 617-621 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Waga, K.: "Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells."Oncogene. 22. 59-68 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakamura, F.: "Monocytic leukemia with CALM/AF10 rearrangement showing mediastinal emphysema."Am J Hematol. 72. 138-142 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Qiao, Y.: "Identification of a novel fusion gene, TTL, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis."Leukemia. 17. 1112-1120 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Imai, Y.: "The corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1."Mol Cell Biol. 24. 1033-1043 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Maki, K.: "Leukemia-related transcription factor TEL is negatively regulated through ERK-induced phosphorylation."Mol Cell Biol. 24. 3227-3237 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamaguchi, Y.: "AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues."J Biol Chem. 279. 15630-15638 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ichikawa, M.: "AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis."Nat Med. 10. 299-304 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kurokawa, M., Mitani, K., Yamagata, T., Takahashi, T., Izutsu, K., Ogawa, S., Moriguchi, T., Nishida, E., Yazaki, Y., Hirai, H.: "The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death."3160. 19. 2958-2968 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Imai, Y., Kurokawa, M., Izutsu K., Hangaishi, A., Takeuchi, K., Maki, K., Ogawa, S., Chiba, S., Mitani, K., Hirai, H.: "Mutations of the AML1 gene in patients with myelodysplastic syndrome and their functional implications in leukemogenesis."Blood. 86. 3154 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamagata, T., Mitani, K., Oda, H., Suzuki, T., Honda, H., Asai, T., Maki, K., Nakamoto, T., Hirai, H.: "Acetylation of GATA-3 affects T-cell survival and homing to secondary lymphoid organ."EMBO J. 19. 4676-4687 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Mitani, K., Yamagata, T., Iida, C., Oda, H., Maki, K., Ichikawa, M., Asai, T., Honda, H., Kurokawa, M., Hirai, H.: "Nonredundant roles of the elongation factor MEN in p5ostimplantation development."Biochem Biophys Res Comm. 279. 563-56 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Imai, Y., Kurokawa, M., Izutsu, K., Hangaishi, A., Maki, K., Ogawa, S., Chiba, S., Mitani, K., Hirai, H.: "Mutations of the Smad4 gene in acute [ leukemia and their functional implications in leukemogenesis."Oncogene. 20. 88-96 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tadokoro, J., Nakamura, Y., Furisawa, S., Mitani K.: "Low frequency of BCL1O gene mutations in B-cell Non-Hodgkin's lymphoma."Int J Hematol. 73. 222-225 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Izutsu, K., Kurokawa, M., Imai, Y., Maki, K., Mitani, K., Hirai, H.: "The corepressor CtBP interacts with Evi-1 to repress transforming growth β signaling."Blood. 97. 2815-2822 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hirai, H., Izutsu, K., Kurokawa, M., Mitani, K.: "Oncogenic mechanisms of Evi-1 protein."Cancer Chem Pharm. 48. S35-S40 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Omine, K., Ota, J., Ueda, M., Ueno, S., Yoshida, K., Yamashita, Y., Kirito, K., Imagawa, S., Nakamura, Y., Saito, K., Akutsu, M., Mitani, K., Kano, Y., Komatsu, N., Ozawa, K., Mano, H.: "Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells."Oncogene. 20. 8249-8257 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakamura, Y., Nakazato, H., Sato, Y., Furusawa, S., Mitani, K.: "Expression od the TEL/B VII fusion transcript in a patient with chronic myelogenous leukemia with t(3;12)(q26;p13)."Am J Hematol. 69. 80-82 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Izutsu, K., Kurokawa, M., Imai, Y., Ichikawa, M., Asai, T., Maki, K., Mitani, K., Hirai, H.: "The t(3;21) fusion product, AML1/Evi-1, blocks AML1-induced transactivation by recruiting CtB"Oncogene. 21. 2695-2703 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Irnai, Y., Kurokawa, M., Izutsu, K., Hangaishi, A., Maki, K., Ogawa, S., Chiba, S., Mitani, K., Hirai, H.: "Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome."Leuk & Lymph. 43. 617-621 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tsurumi, S., Nakamura, Y., Maki, M., Omine, M., Fujita, K., Okamura, T., Niho, Y., Hashimoto, S., Kanno, K., Suzuki, K., Hangaishi, A., Ogawa, S., Hirai, H.Mitani, K.: "N-ras and p53 gene mutations in Japanese patients with myeloproliferative disorders."Am J Hematol. 71. 131-133 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Arai, H., Maid, K., Waga, K., Sasaki, K., Nakamura, Y., Imai, Y., Kurokawa, M., Hirai, H., Mitani, K.: "Functional regulation of TEL by p38-induced phosphorylation."Biochem Biophys Res Comm. 299. 116-125 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Waga, K., Nakamura, Y., Maki, K., Arai, H., Yamagata, T., Sasaki, K., Kurokawa, M., Hirai, H., Mitani, K.: "Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells."Oncogene. 22. 59-68 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakamura, F., Maki, K., Arai, Y., Nakamura, Y., Mitani, K.: "Monocytic leukemia with CALM/AF1O rearrangement showing mediastinal emphysema."Am J Hematol. 72. 138-142 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Qiao, Y., Ogawa, S., Hangaishi, A., Yuji, K., Izutsu, K., Kunisato, A., Imai, Y., Wang, L., Hosoya, N., Nannya, Y., Sato, Y., Maki, K., Mitani, K., Hirai, H.: "Identification of a novel fusion gene, TTh, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis."Leukemia. 17. 1112-1120 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Linai, Y., Kurokawa, M., Yamaguchi, Y., Izutsu, K., Nitta, E., Mitani, K., Satake, M., Noda, T., Ito, Y., Hirai, H.: "The corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1."Mol Cell Biol. 24. 1033-1943 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Maki, K., Arai, H., Waga, K., Sasaki, K., Nakamura, F., Imai, Y., Kurokawa, M., Hirai, H., Mitani, K.: "Leukemia-related transcription factor TEL is negatively regulated through ERK-induced phosphorylation."Mol Cell Biol. 24. 3227-3237 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamaguchi, Y., Kurokawa, M, Imai, Y., Izutsu, K., Asai, T., Ichikawa, M., Yamamoto, G., Nitta, E., Yamagata, T., Sasaki, K., Mitani, K., Ogawa, S., Chiba, S., Hirai, H.: "AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues."J Biol Chem. 279. 15630-15638 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ichikawa, M., Asai, T., Saito, T., Yamamoto, G., Seo, S., Yamazaki, I., Yamagata, T., Mitani, K., Chiba, S., Hirai, H., Ogawa, S., Kurokawa, M.: "AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis."Nat Med. 10. 299-304 (2004)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi